日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RET

在RET突变阳性甲状腺髓样癌患者中,针对selpercatinib的单臂LIBRETTO-001试验的真实世界外部对照组:RECALIB-RET

Hadoux, J; Hernando, J; Wong, K H; Do Cao, C; Lasolle, H; Buffet, C; Benisvy, D; Illouz, F; Schneegans, O; Varnier, R; Drui, D; Zanetta, S; Hescot, S; Muller, M; Nascimento, C; Roudaut, N; Khanal, M; Zheng, S; Li, X; Singh, R; Tian, W; Afonso, A S; Houot, B; Borget, I; Segall, G

Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study

法国十二指肠神经内分泌肿瘤(D-NET)患者的生存情况:GTE 研究组一项为期 20 年的多中心队列研究:一项队列研究

Mekkan-Bouv Hez, M; Derbey, L; de Mestier, L; Lorenzo, D; Walter, T; Perrier, M; Cadiot, G; Goichot, B; Pracht, M; Lièvre, A; Coriat, R; Valancot, S; Guimbaud, R; Carrere, N; Bacoeur-Ouzillou, O; Belleannée, G; Smith, Denis; Laboureau, S; Hescot, Sophie; Julie, Catherine; Teissier, M P; Thereaux, J; Ferru, A; Evrard, C; Mathonnet, M; Christou, N

Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine

在临床常规中,利用定制的NGS panel进行肿瘤突变负荷评估和标准化生物信息学方法

Dupain, Célia; Gutman, Tom; Girard, Elodie; Kamoun, Choumouss; Marret, Grégoire; Castel-Ajgal, Zahra; Sablin, Marie-Paule; Neuzillet, Cindy; Borcoman, Edith; Hescot, Ségolène; Callens, Céline; Trabelsi-Grati, Olfa; Melaabi, Samia; Vibert, Roseline; Antonio, Samantha; Franck, Coralie; Galut, Michèle; Guillou, Isabelle; Halladjian, Maral; Allory, Yves; Cyrta, Joanna; Romejon, Julien; Frouin, Eleonore; Stoppa-Lyonnet, Dominique; Wong, Jennifer; Le Tourneau, Christophe; Bièche, Ivan; Servant, Nicolas; Kamal, Maud; Masliah-Planchon, Julien

The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classification

靶向治疗对机构分子肿瘤委员会识别的分子改变的影响:基于ESCAT分类的方法

Rahmani Narj Abadi, K; Dupain, C; Guillou, I; Sanchez, R; Nedara, K; Marret, G; Hescot, S; Sablin, M-P; Castel-Ajgal, Z; Neuzillet, C; Borcoman, E; Bello Roufai, D; Rodrigues, M; Asnacios Lecerf, A; Callens, C; Trabelsi-Grati, O; Melaabi, S; Driouch, K; Antonio, S; Lemaitre, E; Nijnikoff, M; Vincent Salomon, A; Allory, Y; Cyrta, J; Ghazelian, H; Girard, E; Servant, N; Stoppa-Lyonnet, D; Wong, J; Hamza, A; Masliah-Planchon, J; Kamal, M; Bièche, I; Le Tourneau, C

THU474 Primary Hyperaldosteronism As A Cause Of PTH Elevation After Parathyroid Surgery

THU474 原发性醛固酮增多症是甲状旁腺手术后PTH升高的原因

Chandran, Sindhu; Li, Hui; Dong, Wuxing; Krasinska, Karolina; Adams, Chris; Alexandrova, Ludmila; Chien, Allis; Hallows, Kenneth R; Bhalla, Vivek; Bessiene, Laura; Perrot, Julie; Hescot, Segolene; Bourdin-Pintueles, Alexandra; Vitellius, Geraldine; Sachs, Laurent M; Kamenicky, Peter; Lombes, Marc; Pussard, Eric; Viengchareun, Say; Martinerie, Laetitia; Thi, Wai Phyo; Rao, Ambika

Screening for Prognostic Biomarkers in Metastatic Adrenocortical Carcinoma by Tissue Micro Arrays Analysis Identifies P53 as an Independent Prognostic Marker of Overall Survival

通过组织微阵列分析筛选转移性肾上腺皮质癌的预后生物标志物,发现P53是总生存期的独立预后标志物。

Hescot, Segolene; Faron, Matthieu; Kordahi, Manal; Do Cao, Christine; Naman, Annabelle; Lamartina, Livia; Hadoux, Julien; Leboulleux, Sophie; Pattou, Francois; Aubert, Sébastien; Scoazec, Jean-Yves; Al Ghuzlan, Abir; Baudin, Eric

Significant response to pralsetinib in a medullary thyroid cancer harboring double RET variants of unknown significance

在携带意义不明的双重RET变异的髓样甲状腺癌中,普拉替尼治疗取得了显著疗效。

Hescot, Ségolène; Masliah-Planchon, Julien; du Rusquec, Pauline; Dupain, Célia; Kamal, Maud; Servois, Vincent; Bieche, Ivan

Thyroid cells seeding along the transaxillary approach after robot-assisted transaxillary surgery (RATS) for a benign node

良性淋巴结机器人辅助经腋窝手术(RATS)后,甲状腺细胞沿经腋窝入路播散。

Louvel, Rémy; Badois, Nathalie; Klijanienko, Jerzy; Hescot, Ségolène; Hoffmann, Caroline

Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy

接受免疫疗法治疗的转移性实体瘤患者的反应不一致

Vaflard, Pauline; Paoletti, Xavier; Servois, Vincent; Tresca, Patricia; Pons-Tostivint, Elvire; Sablin, Marie-Paule; Ricci, Francesco; Loirat, Delphine; Hescot, Ségolène; Torossian, Nouritza; Bello Roufai, Diana; Kamal, Maud; Borcoman, Edith; Le Tourneau, Christophe

A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours

一项 1 期剂量递增研究,旨在评估 AsiDNA(一种首创的 DNA 修复抑制剂)在晚期实体瘤患者中静脉注射给药的安全性、药代动力学和药效学。

Le Tourneau, Christophe; Delord, Jean-Pierre; Kotecki, Nuria; Borcoman, Edith; Gomez-Roca, Carlos; Hescot, Ségolène; Jungels, Christiane; Vincent-Salomon, Anne; Cockenpot, Vincent; Eberst, Lauriane; Molé, Audrey; Jdey, Wael; Bono, Françoise; Trochon-Joseph, Véronique; Toussaint, Hélène; Zandanel, Christelle; Adamiec, Olga; de Beaumont, Olivier; Cassier, Philippe Alexandre